How Much Does an Infusion Cost? Site of Care, Biologics, and Your Bill (2026)

Start with cost: why infusion bills are so high

If you are staring at a bill in the thousands or tens of thousands for a single infusion, you are not misreading it. Infused and injectable biologics are genuinely among the most expensive treatments in medicine, and a few things stack up to produce the number you see.

The drug itself. Specialty biologics can carry list prices of thousands to tens of thousands of dollars per dose, so the largest single line on the bill is frequently the medicine. These drugs are usually paid under your medical benefit (not the pharmacy benefit), and the provider often buys the drug and bills your plan for it, an arrangement commonly called buy-and-bill. On the itemized bill the drug shows up as a HCPCS J-code with a number of units.

The administration and facility fee. On top of the drug, you are billed for administering it, using CPT infusion or injection codes such as 96365, 96413, 96372, and time-based add-on codes. In a hospital outpatient setting there is also a separate facility fee, a charge for the room and overhead, which can be several hundred dollars or more and does not appear when the same infusion is done in a physician office.

How the price is set. Under Medicare, most Part B drugs are paid at Average Sales Price (ASP) plus 6 percent, and certain qualifying biosimilars at ASP plus 8 percent of the reference product for a time. Commercial plans negotiate their own rates, often a percentage of the drug’s list price and typically higher than Medicare, so the same J-code can be priced very differently across plans and settings.

The deeper mechanics of buy-and-bill, white and brown bagging, and biosimilar substitution are their own topic. If you want that level of detail, see our specialty pharmacy billing guide at /blog/specialty-pharmacy-billing. On this page we focus on cost and what you can do about the bill.

The single biggest lever: site of care

Where the infusion happens can change the total more than any other single factor. The same infusion, same drug, same dose commonly costs roughly 2 to 5 times more (and by some analyses up to about 7 times more) in a hospital outpatient department than in a physician office, a freestanding (non-hospital) infusion center, or at home. Most of that gap is the hospital facility fee and higher negotiated rates, not a difference in the medicine. This is why two people on the exact same medication can see very different bills.

If you are medically stable and your plan and prescriber agree it is appropriate, this is the highest-value question to ask: “Can this infusion be done in a physician office, a freestanding (non-hospital) infusion center, or through home infusion instead of the hospital outpatient department, and would that lower my cost?“

Many commercial plans have a formal site-of-care program with a nurse or case manager who can help arrange the switch. Confirm the alternate site and any home-infusion pharmacy are in-network before the first visit, because the setting your plan prefers for cost is not always the one the referral defaults to.

• Hospital outpatient department: usually the highest total because of the facility fee and higher negotiated rates.
• Physician office or freestanding infusion center: often materially lower for the same drug and service.
• Home infusion: can be an option for stable, ongoing therapy, with prescriber and plan sign-off.
• Always confirm the alternate site and any home-infusion or specialty pharmacy are in-network first.

What an infusion actually costs in 2026

Treat every number below as a general range and a starting point to verify against your own itemized bill and EOB, not a quote. Pricing varies widely by drug, dose, plan, and setting. Many biologics are dosed by body weight, so the units billed and the cost scale with the patient, and these drugs are priced under the medical benefit rather than as a flat pharmacy copay.

Autoimmune and inflammatory biologics given by IV or injection (the class of therapies that includes infliximab, adalimumab, vedolizumab, and ustekinumab) commonly run from roughly a few thousand dollars up to five figures per dose at list or allowed prices, with hospital-outpatient totals landing at the high end once the facility fee is added.

IVIG (immune globulin) is dosed by weight and is often one of the largest bills, frequently five figures per infusion for a full course-weight dose. Iron infusions are usually far lower, often in the mid hundreds to low thousands per session depending on the product and the number of sessions.

Administration and facility charges are billed on top of the drug. Office infusion administration is often on the order of tens to a few hundred dollars, while a hospital facility fee can add several hundred dollars or more.

What you actually pay with insurance

For in-network, covered care, most insured patients pay coinsurance (a percentage) rather than a flat copay on these high-cost drugs. That means a large drug charge can translate into a large member share until you hit your plan’s out-of-pocket maximum.

For 2026, the ACA caps in-network out-of-pocket spending on essential health benefits at $10,600 for an individual and $21,200 for a family for non-grandfathered plans. Once you reach it, the plan covers 100 percent of remaining in-network covered costs for the year. A high-cost recurring infusion often pushes patients to their out-of-pocket max early in the plan year, which is exactly why in-network status and site of care are worth checking before treatment.

Two big caveats matter here. First, that cap applies only to in-network, covered services, so an out-of-network infusion site, provider, or home-infusion pharmacy can bill amounts that do not count toward the cap and are not limited by it. Second, the federal No Surprises Act protects you from surprise out-of-network bills mainly for emergency care and for out-of-network clinicians at in-network facilities. It does not clearly cover a scheduled infusion you receive at a fully out-of-network site, so network status still matters.

Self-help checks before you pay a dollar

Before paying, work through these checks. Each one is something you can verify yourself, and any one of them can be the reason the bill is higher than it should be. Frame each as something to check, not an accusation. Billing and coding errors are common and usually fixable.

• Confirm network status of everything, separately: the ordering physician, the infusion site (hospital vs. office vs. freestanding center), and any home-infusion or specialty pharmacy. Each can be in- or out-of-network independently, and an out-of-network piece can blow past your out-of-pocket cap.
• Request the fully itemized bill (not the summary). Look for the drug’s HCPCS J-code, the number of units billed, the CPT administration codes (for example 96365, 96413, 96372 and time add-ons), and any separate facility or revenue-code fee.
• Check the drug units and dosing. Many biologics are dosed per kilogram or per milligram; multiply the expected dose by the J-code’s unit definition and compare to the units billed. A units error can multiply the drug charge.
• Check for wastage and the JW modifier. If a single-dose vial had leftover drug that was discarded, that discarded amount should be billed with the JW modifier; if nothing was discarded, the line carries the JZ attestation instead (the two are mutually exclusive on a given drug line). Confirm the total billed units are not more than one vial’s worth beyond your dose.
• Match the itemized bill to your Explanation of Benefits (EOB) line by line. The EOB shows the plan’s allowed amount, what the plan paid, and your responsibility. If the provider is in-network, you generally owe the allowed amount, not the higher gross charge.
• Confirm the facility fee. If you were treated in a hospital outpatient department, identify the facility fee as a distinct line and ask whether the same service was available at a lower-cost site.
• Verify prior authorization was obtained. Many biologics require it, and a denial for missing or expired authorization is often fixable and should not simply be passed to you as balance due.

Ways to reduce the cost

Once you understand the bill, several levers can bring the total down. Some are one-time fixes to an incorrect bill; others change the cost of ongoing treatment going forward.

• Ask about a site-of-care change. Moving a stable, ongoing infusion from a hospital outpatient department to a physician office, a freestanding infusion center, or home infusion (with prescriber and plan sign-off, and confirmed in-network) is often the single largest saver because it removes or reduces the facility fee.
• Use manufacturer copay cards and patient assistance. Many biologic makers offer copay-assistance cards for commercially insured patients and income-based patient assistance programs for the uninsured or underinsured. Note that copay cards generally cannot be used with Medicare or Medicaid. See /blog/patient-assistance-programs for how these work.
• Look into independent charitable foundations. Disease-specific foundations and copay-relief charities may help with coinsurance for a given condition, including for patients on Medicare who cannot use manufacturer copay cards.
• Ask about biosimilars. For several biologics, a lower-cost biosimilar exists and may reduce the drug charge; discuss suitability with your prescriber and plan. The specialty pharmacy billing guide at /blog/specialty-pharmacy-billing explains how substitution works.
• Appeal a denial. If the plan denied the drug, the site, or the authorization, you have the right to an internal appeal and then an external review, and a peer-to-peer review by your prescriber often resolves medical-necessity denials. See /blog/medication-denial-appeal for the steps.
• Have the bill audited. Ask for a line-by-line review of J-code units, administration codes, wastage, and the facility fee against your EOB, and request correction of any coding or unit errors before paying.
• Ask about financial assistance and payment plans. Hospitals and many infusion providers have financial-assistance (charity care) policies and interest-free payment plans; request the policy and application in writing.

Get help with the bill: CareRoute Bill Defense

If this is overwhelming, you do not have to work through it alone. CareRoute Bill Defense can review your itemized bill and EOB, check network and site-of-care options, verify J-code units and facility fees, and pursue copay assistance or an appeal on your behalf.

We do not promise a specific dollar outcome. What we do is make sure you are only charged for what you actually owe, and that every check on this page has been done properly before you pay. If you have an infusion or biologic bill that looks wrong or simply too large to face, that is exactly the kind of case Bill Defense is built for.

Frequently asked questions

Related resources